Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Guardant Health, Inc. - Common Stock
(NQ:
GH
)
72.15
+2.80 (+4.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health, Inc. - Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Guardant Health to Participate in Upcoming March Investor Conferences
February 17, 2023
From
Guardant Health, Inc.
Via
Business Wire
25 AI Stocks to Buy Right Now
February 16, 2023
Looking to benefit from the AI boom started by ChatGPT? Here are the best AI stocks to buy for the emerging market frenzy.
Via
InvestorPlace
Guardant Health Initiates New Study to Examine the Impact of Shield™ Blood Test to Increase Screening Compliance for Colorectal Cancer
February 15, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health receives coverage from UnitedHealthcare for Guardant360® CDx blood test as companion diagnostic in advanced lung and breast cancer
February 08, 2023
From
Guardant Health, Inc.
Via
Business Wire
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
February 04, 2023
Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a...
Via
Talk Markets
Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360® CDx and Guardant360 TissueNext™ as Companion Diagnostics for Taletrectinib in Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
February 02, 2023
From
Guardant Health Inc.
Via
Business Wire
Magistrate Judge Issues Favorable Recommendation Regarding Guardant Health’s Motion to Dismiss Lawsuit Brought by Illumina
February 02, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
February 01, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health introduces Guardant GalaxyTM suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery
January 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health receives FDA approval for Guardant360® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer
January 30, 2023
From
Guardant Health, Inc.
Via
Business Wire
Down 40% in 2022, Can Exact Sciences Recover in 2023?
January 23, 2023
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.
Via
The Motley Fool
Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal™ blood test to help guide treatment decisions in colorectal cancer
January 19, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to showcase new data at ASCO GI 2023 demonstrating utility of its blood tests for patients with gastrointestinal cancers
January 17, 2023
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
January 11, 2023
Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.
Via
Benzinga
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2022 Results
January 09, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 28, 2022
From
Guardant Health, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
December 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Guardant Health and Susan G. Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy
December 21, 2022
From
Guardant Health, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Barron's Top Weekend Stock Picks: AMD, Ford, Accenture And Should Tesla CEO Elon Musk Be Replaced?
December 17, 2022
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Via
Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
December 16, 2022
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 16, 2022
Via
Benzinga
This Nasdaq Healthcare Stock's Pain Is Its Rival's Gain
December 16, 2022
The broader market lost more ground on Friday.
Via
The Motley Fool
AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy?
December 16, 2022
Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing.
Via
InvestorPlace
Why Is Exact Sciences (EXAS) Stock Up 23% Today?
December 16, 2022
Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected.
Via
InvestorPlace
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results
December 16, 2022
Guardant spent more money than it took in while hoping to become a leader in cancer diagnosis, but accuracy remains a problem.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
December 16, 2022
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 16, 2022
We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!
Via
InvestorPlace
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 16, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.